Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 86
  2. 87
  3. 88
  4. 89
  5. 90
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Clenoliximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5193-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Clenoliximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5193-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Clenoliximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5193-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Emicizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5178-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Emicizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5178-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Mogamulizumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5186B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Mogamulizumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5186HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Oxelumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5187D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Briakinumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other FA ICH5188B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Briakinumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5188D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Briakinumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other FA ICH5188HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Basiliximab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5189D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5158UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5182UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Clenoliximab Biosimilar -­ Research Grade Anmelden Clenoliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Clenoliximab Biosimilar -­ Research Grade Anmelden Clenoliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Clenoliximab Biosimilar -­ Research Grade Anmelden Clenoliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Emicizumab Biosimilar -­ Research Grade Anmelden Emicizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Emicizumab Biosimilar -­ Research Grade Anmelden Emicizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Mogamulizumab Biosimilar -­ Biotin Research Grade Anmelden Mogamulizumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Mogamulizumab Biosimilar -­ HRP Research Grade Anmelden Mogamulizumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Oxelumab Biosimilar -­ Dylight488 Research Grade Anmelden Oxelumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Briakinumab Biosimilar -­ Biotin Research Grade Anmelden Briakinumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl. FA
Host
ArtNr.
Menge 100 ug
Lieferbar
Briakinumab Biosimilar -­ Dylight488 Research Grade Anmelden Briakinumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Briakinumab Biosimilar -­ HRP Research Grade Anmelden Briakinumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl. FA
Host
ArtNr.
Menge 100 ug
Lieferbar
Basiliximab Biosimilar -­ Dylight488 Research Grade Anmelden Basiliximab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Zilovertamab Biosimilar -­ Ultra Low Endotoxin Anmelden Zilovertamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Ponsegromab Biosimilar -­ Ultra Low Endotoxin Anmelden Ponsegromab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 86
  2. 87
  3. 88
  4. 89
  5. 90
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top